Cargando…
The application and efficacy of stent place for Budd-Chiari syndrome
Objective To evaluate the application value and efficacy on stent place for Budd-Chiari syndrome (BCS). Methods From January 1990 to May 2017, 2228 patients with BCS were admitted to our institution. The mean age was 43.3 years. Stents were placed in inferior vena cava (IVC), hepatic vein (HV), or b...
Autores principales: | Zu, Maoheng, Xu, Hao, Gu, Yuming, Zhang, Qingqiao, Wei, Ning, Xu, Wei, Cui, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Journal of Interventional Radiology Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586564/ https://www.ncbi.nlm.nih.gov/pubmed/34805846 http://dx.doi.org/10.19779/j.cnki.2096-3602.2018.03.07 |
Ejemplares similares
-
Review of Budd-Chiari Syndrome
por: Zu, Maoheng, et al.
Publicado: (2020) -
Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis
por: ZHANG, QINGQIAO, et al.
Publicado: (2013) -
Experts consensus on Chinese nomenclature of Budd-Chiari syndrome
por: Zu, Maoheng, et al.
Publicado: (2021) -
Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014) -
Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome
por: Lu, Qinwei, et al.
Publicado: (2021)